Free Trial
→ Important SpaceX PREDICTION (From Banyan Hill Publishing) (Ad)tc pixel Free AGL Stock Alerts

Agilon Health (AGL) Short Interest Ratio & Short Volume

Agilon Health logo
$115.38 +13.68 (+13.45%)
Closing price 06/11/2026 03:59 PM Eastern
Extended Trading
$115.00 -0.38 (-0.33%)
As of 06/11/2026 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Agilon Health Short Interest Overview

As of May 29, 2026, Agilon Health (AGL) had a short interest of 632,194 shares sold short, representing 3.88% of the public float. This marks a -1.18% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.1, meaning it would take 2.1 days of the average trading volume of 284,587 shares to cover all short positions.

Current Short Interest
632,194 shares
Previous Short Interest
639,741 shares
Change Vs. Previous Month
-1.18%
Dollar Volume Sold Short
$57.90 million
Short Interest Ratio
2.1 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
16,680,000 shares
Short Percent of Float
3.88%
Today's Trading Volume
211,270 shares
Average Trading Volume
284,587 shares
Today's Volume Vs. Average
74%
Short Selling Agilon Health?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Agilon Health and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AGL Short Interest Over Time

AGL Days to Cover Over Time

AGL Percentage of Float Shorted Over Time

Agilon Health Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/2026632,194 shares $57.90 million -1.2%3.9%2.06 $91.58
5/15/2026639,741 shares $52.49 million -19.2%3.9%0.8 $82.05
4/30/2026791,524 shares $22.15 million -20.9%4.9%1.85 $27.99
4/15/20261,000,735 shares $26.96 million -26.3%6.2%2.28 $26.94
3/31/20261,357,594 shares $10.80 million -94.9%8.4%7.08 $7.96
3/13/202626,654,381 shares $16.13 million +8.4%6.6%5.39 $0.61
2/27/202624,591,484 shares $14.46 million +20.5%6.1%3.28 $0.59
2/13/202620,413,986 shares $7.37 million +1.2%5.0%1.85 $0.36
1/30/202620,177,282 shares $16.85 million -1.1%5.0%3.46 $0.84
1/15/202620,406,494 shares $20.71 million +5.2%5.1%2.93 $1.02
12/31/202519,389,860 shares $13.35 million -6.1%4.9%4.07 $0.69
12/15/202520,639,623 shares $13.68 million +15.1%5.2%2.35 $0.66
11/28/202517,931,905 shares $11.92 million -13.8%4.5%1.39 $0.67
11/14/202520,803,215 shares $11.96 million -0.4%5.2%1.42 $0.58
10/31/202520,881,325 shares $16.58 million +2.4%5.2%3.07 $0.79
10/15/202520,400,000 shares $20.71 million +3.1%6.7%1.8 $1.02
9/30/202519,790,000 shares $20.38 million -13.2%6.5%1.9 $1.03
9/15/202522,790,000 shares $25.41 million +25.4%7.5%2.2 $1.12
8/31/202518,170,000 shares $23.17 million -4.9%6.0%1.9 $1.28
8/15/202519,110,000 shares $21.21 million +1.0%6.3%2.1 $1.11
7/31/202518,920,000 shares $33.77 million +6.2%6.2%2.3 $1.79
7/15/202517,820,000 shares $39.11 million -14.5%5.9%4.4 $2.20
6/30/202520,840,000 shares $48.14 million -1.8%6.9%4.1 $2.31
6/15/202521,230,000 shares $45.75 million +5.8%7.0%4.1 $2.16
5/31/202520,070,000 shares $44.56 million -9.6%6.6%3.6 $2.22
5/15/202522,200,000 shares $56.61 million +1.1%7.3%3.6 $2.55
4/30/202521,960,000 shares $93.55 million +14.8%7.3%3.6 $4.26
4/15/202519,130,000 shares $105.88 million +4.7%6.3%3.2 $5.54
3/31/202518,270,000 shares $79.02 million -1.6%6.1%3.1 $4.33
3/15/202518,560,000 shares $75.63 million +10.3%6.1%3.4 $4.08
2/28/202516,820,000 shares $52.48 million -9.1%5.5%3.4 $3.12
2/15/202518,500,000 shares $63.36 million -8.6%6.1%4 $3.43
1/31/202520,240,000 shares $67.70 million -19.8%6.7%4.5 $3.35
1/15/202525,250,000 shares $71.46 million -9.0%8.3%5.9 $2.83
12/31/202427,760,000 shares $52.74 million -6.8%9.2%6.9 $1.90
12/15/202429,790,000 shares $66.73 million -6.7%9.8%6.8 $2.24
11/30/202431,940,000 shares $66.75 million +5.1%10.5%7 $2.09
11/15/202430,390,000 shares $48.17 million -16.1%10.0%6.4 $1.59
10/31/202436,220,000 shares $92.54 million +1.0%12.0%7.9 $2.56
10/15/202435,880,000 shares $119.12 million -1.7%11.9%8.2 $3.32
Is your wealth prepared for “America’s Most Dangerous Man”? (Read before June 16) (Ad)

60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab the Washington Post calls 'may be the single most powerful company in the world' - a figure whose technology has already erased $1 trillion from markets in under a week. Chaikin believes this AI lab's pending IPO could be the biggest of 2026 - and he's identified a little-known $40 stock he calls a 'pre-IPO backdoor' play ahead of a potential multitrillion-dollar market shift as early as June 16.tc pixel

Get the name of Marc Chaikin's No. 1 stock before June 16
9/30/202436,490,000 shares $143.41 million -7.4%12.1%8.3 $3.93
9/15/202439,420,000 shares $139.15 million -4.2%13.0%8.3 $3.53
8/31/202441,150,000 shares $167.89 million +6.3%13.6%9 $4.08
8/15/202438,700,000 shares $190.79 million -12.3%12.8%8.8 $4.93
7/31/202444,140,000 shares $304.35 million -3.8%14.6%9.7 $6.90
7/15/202445,860,000 shares $299.92 million +5.9%15.2%10.3 $6.54
6/30/202443,310,000 shares $283.25 million -0.7%14.3%9.8 $6.54
6/15/202443,620,000 shares $300.98 million -0.6%14.4%10.7 $6.90
5/31/202443,890,000 shares $276.51 million -1.7%14.5%10.4 $6.30
5/15/202444,660,000 shares $236.70 million +0.9%14.7%9.7 $5.30
4/30/202444,280,000 shares $243.32 million -3.8%14.6%9.3 $5.50
4/15/202446,020,000 shares $205.25 million -2.1%15.3%8.9 $4.46
3/31/202447,020,000 shares $286.82 million +0.1%15.5%7.7 $6.10
3/15/202446,960,000 shares $250.06 million -2.1%15.5%8 $5.33
2/29/202447,970,000 shares $293.10 million +4.0%15.9%8.7 $6.11
2/15/202446,120,000 shares $334.37 million +3.1%15.4%8.8 $7.25
1/31/202444,750,000 shares $263.80 million -5.8%15.0%8.6 $5.90
1/15/202447,490,000 shares $350.48 million +4.2%15.9%10.3 $7.38
12/31/202345,590,000 shares $572.15 million -3.2%15.2%11.6 $12.55
12/15/202347,090,000 shares $615.94 million -3.9%15.7%14.9 $13.08
11/30/202348,980,000 shares $520.17 million -0.7%16.3%16.4 $10.62
11/15/202349,330,000 shares $616.13 million +6.4%16.4%17.8 $12.49
10/31/202346,380,000 shares $834.84 million +4.0%15.5%18.9 $18.00
10/15/202344,590,000 shares $809.31 million +1.6%14.9%20.4 $18.15
9/30/202343,880,000 shares $779.31 million +3.2%14.6%18.8 $17.76
9/15/202342,520,000 shares $797.25 million +5.8%14.2%18.2 $18.75
8/31/202340,190,000 shares $712.17 million +10.5%13.3%15.2 $17.72
8/15/202336,380,000 shares $665.03 million -4.5%12.0%12.8 $18.28
7/31/202338,080,000 shares $729.42 million -3.2%12.6%10.6 $19.16
7/15/202339,320,000 shares $656.64 million +4.0%12.7%11.4 $16.70
6/30/202337,820,000 shares $655.80 million +9.6%12.2%11.1 $17.34
6/15/202334,510,000 shares $645.68 million +10.1%11.2%9.2 $18.71
5/31/202331,350,000 shares $623.24 million -15.8%10.2%8.9 $19.88
5/15/202337,210,000 shares $885.97 million +1.2%12.1%10.5 $23.81
4/30/202336,780,000 shares $892.65 million -0.4%17.2%13.7 $24.27
4/15/202336,940,000 shares $1.05 billion -2.7%17.4%13.7 $28.46
3/31/202337,960,000 shares $901.55 million +2.1%17.9%14.3 $23.75
3/15/202337,170,000 shares $888.73 million +11.0%17.6%17.1 $23.91
2/28/202333,490,000 shares $710.32 million +2.4%16.0%16.5 $21.21
2/15/202332,720,000 shares $772.19 million +8.1%15.7%17.6 $23.60
1/31/202330,260,000 shares $658.46 million +6.1%14.5%15.7 $21.76
1/15/202328,520,000 shares $565.55 million +3.0%13.7%15.6 $19.83
12/30/202227,690,000 shares $446.92 million +10.5%13.3%15.1 $16.14
12/15/202225,060,000 shares $431.03 million +11.3%12.0%13.9 $17.20
11/30/202222,520,000 shares $395.45 million -2.9%10.8%10.8 $17.56
11/15/202223,190,000 shares $435.74 million -3.5%11.1%11.1 $18.79
10/31/202224,030,000 shares $477.00 million +5.8%11.5%10.6 $19.85
10/15/202222,720,000 shares $481.21 million +4.0%10.9%9.7 $21.18
9/30/202221,850,000 shares $511.73 million -0.3%10.5%9 $23.42
9/15/202221,920,000 shares $546.90 million +3.0%10.5%8.8 $24.95
Important SpaceX PREDICTION (Ad)

The biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian says investors are about to miss the real opportunity. A little-known FCC filing Elon quietly submitted earlier this year has caught Morgan Stanley's attention — and they estimate it could be worth $40 trillion. That's larger than Tesla, xAI, Starlink, X, Neuralink, and SpaceX combined.tc pixel

Click here for the full breakdown before the IPO date arrives
8/31/202221,290,000 shares $442.41 million +12.5%10.2%9.5 $20.78
8/15/202218,920,000 shares $440.84 million -3.0%9.1%7.9 $23.30
7/31/202219,500,000 shares $488.09 million +1.8%10.1%8.4 $25.03
7/15/202219,160,000 shares $505.63 million -12.8%10.0%8.6 $26.39
6/30/202221,970,000 shares $479.61 million +9.7%11.4%10.6 $21.83
6/15/202220,030,000 shares $380.97 million -2.1%10.4%10.4 $19.02
5/31/202220,460,000 shares $390.79 million -0.5%10.7%10.2 $19.10
5/15/202220,560,000 shares $394.14 million +20.2%10.7%11.4 $19.17
4/30/202217,100,000 shares $303.87 million +11.1%9.1%10.1 $17.77
4/15/202215,390,000 shares $355.05 million +5.3%8.2%8.7 $23.07
3/31/202214,620,000 shares $370.62 million -5.5%8.1%7.9 $25.35
3/15/202215,470,000 shares $305.53 million +8.3%8.5%7.6 $19.75
2/28/202214,290,000 shares $288.94 million +8.4%7.9%6.3 $20.22
2/15/202213,180,000 shares $288.25 million -5.8%7.4%5.9 $21.87
1/31/202213,990,000 shares $231.95 million +8.1%7.9%6.3 $16.58
1/15/202212,940,000 shares $253.75 million +1.3%7.3%6 $19.61
12/31/202112,780,000 shares $345.06 million +48.8%7.2%5.7 $27.00
12/15/20218,590,000 shares $202.21 million +57.6%4.8%4 $23.54
11/30/20215,450,000 shares $119.90 million +51.8%3.1%3.2 $22.00
11/15/20213,590,000 shares $90.97 million +38.1%2.1%2.5 $25.34
10/29/20212,600,000 shares $63.70 million -55.9%1.5%2 $24.50
10/15/20215,900,000 shares $141.36 million +7.3%3.4%5.5 $23.96
9/30/20215,500,000 shares $144.16 million +34.2%3.2%8.2 $26.21
9/15/20214,100,000 shares $127.18 million -23.5%2.4%6.5 $31.02
8/31/20215,360,000 shares $187.60 million +12.1%3.4%9.2 $35.00
8/13/20214,780,000 shares $167.44 million No Change3.0%7.6 $35.03

AGL Short Interest - Frequently Asked Questions

Short interest is the volume of Agilon Health shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 632,194 shares of AGL short. 3.88% of Agilon Health's shares are currently sold short. Learn More on Agilon Health's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGL shares currently have a short interest ratio of 2.1. Learn More on Agilon Health's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.88% of Agilon Health's floating shares are currently sold short.

Agilon Health saw a decrease in short interest during the month of May. As of May 29th, there was short interest totaling 632,194 shares, a decrease of 1.2% from the previous total of 639,741 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

3.88% of Agilon Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Agilon Health: Hims & Hers Health, Inc. (30.66%), PACS Group, Inc. (9.24%), Caris Life Sciences, Inc. (7.59%), Billiontoone, Inc. (3.66%), Sotera Health Company (7.81%), RadNet, Inc. (12.35%), Veracyte, Inc. (9.35%), Option Care Health, Inc. (8.16%), Concentra Group Holdings Parent, Inc. (2.27%), GRAIL, Inc. (15.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling AGL is an investing strategy that aims to generate trading profit from Agilon Health as its price is falling. AGL shares are trading up $13.68 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Agilon Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGL, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AGL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:AGL) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
Is your wealth prepared for “America’s Most Dangerous Man”? (Read before June 16)
60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab t...
Chaikin Analytics | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Live demo of Elon Musk’s AI agent
Jeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This Is How Financial Freedom Dies—And Most People Never See It Coming
While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...
Priority Gold | Sponsoredtc pixel
Jon Najarian: “Make this move now that SPCX is trading”
SpaceX is now publicly trading under the ticker SPCX - but Hall of Fame Trader Jon Najarian says the real oppo...
Banyan Hill Publishing | Sponsoredtc pixel